Suhong Xie

780 total citations
43 papers, 507 citations indexed

About

Suhong Xie is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Suhong Xie has authored 43 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 20 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Suhong Xie's work include DNA Repair Mechanisms (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immune Cell Function and Interaction (4 papers). Suhong Xie is often cited by papers focused on DNA Repair Mechanisms (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immune Cell Function and Interaction (4 papers). Suhong Xie collaborates with scholars based in China, France and Israel. Suhong Xie's co-authors include Lin Guo, Renquan Lu, Yanchun Wang, Hui Zheng, Ailing Zhong, Hongqin Zhang, Xiang Gao, Xuemei Wen, Keyu Zhu and Ying Tong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Suhong Xie

41 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Suhong Xie China	15	278	176	126	88	82	43	507
Rujiao Liu China	12	268 1.0×	250 1.4×	123 1.0×	51 0.6×	130 1.6×	39	580
Satoshi Tsunetoh Japan	15	280 1.0×	243 1.4×	159 1.3×	68 0.8×	67 0.8×	32	715
Corina N.A.M. Oldenhuis Netherlands	9	335 1.2×	192 1.1×	160 1.3×	90 1.0×	98 1.2×	13	544
Ninghua Yao China	13	331 1.2×	117 0.7×	266 2.1×	68 0.8×	79 1.0×	43	516
Peng-Chan Lin Taiwan	15	204 0.7×	245 1.4×	130 1.0×	44 0.5×	57 0.7×	30	540
Xianshuo Cheng China	12	244 0.9×	250 1.4×	211 1.7×	133 1.5×	76 0.9×	26	552
Minna Shen China	9	209 0.8×	203 1.2×	208 1.7×	80 0.9×	71 0.9×	22	520
Ryoji Hashimoto Japan	16	337 1.2×	141 0.8×	82 0.7×	63 0.7×	156 1.9×	23	593
Andrea Pretta Italy	12	182 0.7×	272 1.5×	139 1.1×	59 0.7×	102 1.2×	47	478
Jinjia Chang China	15	430 1.5×	279 1.6×	284 2.3×	72 0.8×	161 2.0×	31	740

Countries citing papers authored by Suhong Xie

Since Specialization

Citations

This map shows the geographic impact of Suhong Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suhong Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suhong Xie more than expected).

Fields of papers citing papers by Suhong Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suhong Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suhong Xie. The network helps show where Suhong Xie may publish in the future.

Co-authorship network of co-authors of Suhong Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Suhong Xie. A scholar is included among the top collaborators of Suhong Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suhong Xie. Suhong Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Dan, et al.. (2025). NSE and ProGRP Are Promising Markers for Diagnosis, Efficacy Evaluation, Follow‐Up Monitoring, and Prognosis of Small Cell Esophageal Carcinoma. Thoracic Cancer. 16(4). e70026–e70026.

Ma, Xiaolu, et al.. (2025). Stemness‐Relevant Gene Signature for Chemotherapeutic Response and Prognosis Prediction in Ovarian Cancer. Stem Cells International. 2025(1). 2505812–2505812. 1 indexed citations

Wu, Hong, et al.. (2025). A pan-cancer analysis targeting the oncogenic role of ATP-binding cassette transporter A1 in human tumors. Frontiers in Oncology. 15. 1513992–1513992. 1 indexed citations

Meng, Xin, Hui Zheng, Xiaolu Ma, et al.. (2023). TPX2 promotes ovarian tumorigenesis by interacting with Lamin A/C and affecting its stability. Cancer Medicine. 12(8). 9738–9748. 5 indexed citations

Zheng, Hui, Xin Meng, Ying Tong, et al.. (2023). IFN-γ in ovarian tumor microenvironment upregulates HLA-E expression and predicts a poor prognosis. Journal of Ovarian Research. 16(1). 229–229. 6 indexed citations

Li, Luying, Peipei Ding, Xinyue Lv, et al.. (2022). CD59-Regulated Ras Compartmentalization Orchestrates Antitumor T-cell Immunity. Cancer Immunology Research. 10(12). 1475–1489. 9 indexed citations

Ma, Xiaolu, Keyu Zhu, Suhong Xie, et al.. (2022). Identification of a novel Calpain-2-SRC feed-back loop as necessity for β-Catenin accumulation and signaling activation in hepatocellular carcinoma. Oncogene. 41(27). 3554–3569. 11 indexed citations

Wang, Yanchun, Suhong Xie, Ying Tong, et al.. (2021). A Risk of Venous Thromboembolism Algorithm as a Predictor of Venous Thromboembolism in Patients with Colorectal Cancer. Clinical and Applied Thrombosis/Hemostasis. 27. 2975246404–2975246404. 3 indexed citations

Yu, Yiwen, Hui Zheng, Yanchun Wang, et al.. (2021). Differentially Expressed Genes in Clear Cell Renal Cell Carcinoma as a Potential Marker for Prognostic and Immune Signatures. Frontiers in Oncology. 11. 776824–776824. 9 indexed citations

10.

Tang, Wei‐Guo, et al.. (2020). Serum STIP1, a Novel Indicator for Microvascular Invasion, Predicts Outcomes and Treatment Response in Hepatocellular Carcinoma. Frontiers in Oncology. 10. 511–511. 15 indexed citations

11.

Zheng, Hui, Ailing Zhong, Suhong Xie, et al.. (2019). Elevated serum HER‐2 predicts poor prognosis in breast cancer and is correlated to ADAM10 expression. Cancer Medicine. 8(2). 679–685. 21 indexed citations

12.

Lu, Renquan, Suhong Xie, Yanchun Wang, et al.. (2019). MUS81 Participates in the Progression of Serous Ovarian Cancer Associated With Dysfunctional DNA Repair System. Frontiers in Oncology. 9. 1189–1189. 14 indexed citations

13.

Xu, Xiaofeng, Ren Huang, Yu Qi, et al.. (2019). Plasma C-MYC Level Manifesting As An Indicator in Progression of Breast Cancer. Biomarkers in Medicine. 13(11). 917–929. 7 indexed citations

14.

Zhang, Hongqin, Guihong Zhang, Ailing Zhong, et al.. (2018). Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer. Biochemical and Biophysical Research Communications. 507(1-4). 74–82. 41 indexed citations

15.

Wang, Yanchun, Hu Tao, Jiabin Shen, et al.. (2018). Capable Infection of Hepatitis B Virus in Diffuse Large B-cell Lymphoma. Journal of Cancer. 9(9). 1575–1581. 31 indexed citations

16.

Zhong, Ailing, Hongqin Zhang, Suhong Xie, et al.. (2018). Inhibition of MUS81 improves the chemical sensitivity of olaparib by regulating MCM2 in epithelial ovarian cancer. Oncology Reports. 39(4). 1747–1756. 18 indexed citations

17.

Zhang, Hongqin, Ailing Zhong, Miaomiao Chen, et al.. (2017). COPS5 inhibition arrests the proliferation and growth of serous ovarian cancer cells via the elevation of p27 level. Biochemical and Biophysical Research Communications. 493(1). 85–93. 18 indexed citations

18.

Weng, Wenhao, Minli Wang, Suhong Xie, et al.. (2014). YY1-C/EBPα-miR34a regulatory circuitry is involved in renal cell carcinoma progression. Oncology Reports. 31(4). 1921–1927. 22 indexed citations

19.

Xie, Suhong, Wenhao Weng, & Zhi Li. (2012). The effect of TET1 on the proliferation of renal cancer 786-O cells and its related mechanism. Tumori. 32(12). 962–968. 1 indexed citations

20.

Tipples, Karen, Rubin Soomal, Elizabeth D. Sherwin, et al.. (2006). Outcomes of chemoradiation for locally advanced pancreatic cancer at Ipswich Hospital 2002-2005. Annals of Oncology. 17. 62–62. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact